New analysis on Cancer Supportive Care Market: Patent Expirations Create Opportunities for Biosimilar in the Chemotherapy Induced Anemia and Neutropenia Markets, 2017 added in Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Cancer Supportive Care Industry in subject line and your contact details. Complete Report on Sports Medicine Market is Available at http://www.reportsnreports.com/reports/974418-global-cancer-supportive-caretherapeutics-market-to-2022-patent-expirations-create-opportunities-for-biosimilars-in-thechemotherapy-induced-anemia-and-neutropenia-markets.html . The report “Cancer Supportive Care Market: Patent Expirations Create Opportunities for Biosimilar in the Chemotherapy Induced Anemia and Neutropenia Markets, 2017” analysis six key indications which are chemotherapy-induced neutropenia (CIN), chemotherapyinduced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV), cancer pain, bone metastasis and oral mucositis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise. The cancer supportive care market report analyzes products in terms of market value (US$ Mn), by drug class, disease indication, region, and distribution channels, and provides information regarding regional market dynamics, regulations, competitive landscape, current trends, market estimations, clinical trials and forecast. Key market participants covered in the cancer supportive care market report include Amgen, Bayer, Heron, INSYS, Kyowa Hakko Kirin, Daiichi Sankyo, Spectrum, Depomed, Johnson & Johnson, Eisai, Ono , Teva, Eli Lilly, Tesaro, Otsuka, Roche, Pfizer, Merck & Co., Shionogi, Orion, GW Pharmaceuticals, Almirall. The report Cancer Supportive Care Market- Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets, 2017 provides an introduction to key indications within cancer supportive care, including disease epidemiology, symptoms, pathophysiology, diagnosis and disease staging and prognosis. The global cancer supportive care market is forecast to experience a low level of growth, with revenue increasing from USD11.7 Billion in 2015 to USD12.4 Billion in 2022 at a compound annual growth rate (CAGR) of 1.08%. The unmet need’s within the cancer supportive care therapy area varies between indications. CIN and CINV both already have treatment regimens that can significantly decrease the incidence rate. However, the level of unmet need for CIA, cancer pain, oral mucositis and bone metastasis is high, with treatment focusing heavily on alleviating the symptoms instead of treating the underlying cause.
There are 245 products in active development in the cancer supportive care pipeline, but this includes products in development for smaller and less commercially significant indications. There are 169 products in active development for the key indication examined in this report, giving an average of 28 products per indication, the majority of which are at an early stage of development. Sample on the Report is Available at http://www.reportsnreports.com/contacts/requestsample.aspx . Scope of the report The cancer supportive care market already contains some commercially successful products. The cancer supportive care pipeline is relatively small, but there is significant diversity in terms of molecule types and targets. The cancer supportive care market is forecast to grow from $11.7 billion in 2015 to $12.4 billion in 2022, at a compound annual growth rate of 0.9%. The company landscape is becoming increasingly competitive. Companies mentioned in this report: Amgen, Bayer, Heron, INSYS, Kyowa Hakko Kirin, Daiichi Sankyo, Spectrum, Depomed, Johnson & Johnson, Eisai, Ono , Teva, Eli Lilly, Tesaro, Otsuka, Roche, Pfizer, Merck & Co., Shionogi, Orion, GW Pharmaceuticals, Almirall. List of Tables Table 1: Cancer Supportive Care Market, Global, Bone Metastasis Grading Table 2: Cancer Supportive Care Market, Global, Oral Mucositis Grading Table 3: Cancer Supportive Care Market, Global, Chemotherapy-Induced Neutropenia Grading Table 4: Cancer Supportive Care Market, Global, Chemotherapy-Induced Anemia Grading Table 5: Cancer Supportive Care Market, Treatment Guidelines for Chemotherapy-Induced Nausea and Vomiting Treatment 18 Table 6: Cancer Supportive Care Market, Treatment Guidelines for Oral Mucositis Table 7: Cancer Supportive Care Market, Global, Approved Indications for Neulasta Table 8: Cancer Supportive Care Market, Global, Approved Indications for Xgeva Table 9: Cancer Supportive Care Market, Global, Approved Indications for Aranesp Table 10: Cancer Supportive Care Market, Global, Approved Indications for Xofigo And More‌ Buy a Copy of Report @ http://www.reportsnreports.com/purchase.aspx. OR Inquire for Discount http://www.reportsnreports.com/contacts/discount.aspx .
Browse All Reports on Pharmaceuticals Market Research Reports.
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & indepth market research studies of over 5000 micro markets.